Replies to post #25938 on Revive Therapeutics Ltd (RVVTF)

[ReikoBlack]

40:55

The compelling story here from an investor perspective is there's really no company in the world that's in a Phase 3 that's worth less than,....right now, eight hundred - a billion. So, you get the best of both worlds with Revive. You have a psychedelic company, one of the top five, and a Phase 3 in Bucillamine. It sets us apart and i'd like, obviously, investors to recognize that.

Revive Therapeutics, Emerging Growth Conference 4/14/21